TickerFactsScreenerDevelopers

PDS Biotechnology Corp (PDSB) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$6.49M2014: -$13.19M2015: -$26.50M2016: -$39.51M2017: -$51.97M2018: -$3.65M2019: -$21.03M2020: -$14.90M2021: -$21.44M2022: -$41.67M2023: -$43.05M2024: -$36.32M2025: -$31.54M-$31.54M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$31.54M+13.2%
2024-$36.32M+15.6%
2023-$43.05M-3.3%
2022-$41.67M-94.4%
2021-$21.44M-43.9%
2020-$14.90M+29.2%
2019-$21.03M-476.9%
2018-$3.65M+93.0%
2017-$51.97M-31.5%
2016-$39.51M-49.1%
2015-$26.50M-100.8%
2014-$13.19M-103.4%
2013-$6.49M—